High-throughput profiling of JAK2-mutant MPN model cells screened out a number of known and novel lncRNA targets that are highly associated with JAK2-V617F signaling pathway and deserve further investigation. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.